Article info
PDFHepatology
Original research
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
- Correspondence to Adriaan J van der Meer, Dept of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam 3015 GD, The Netherlands; a.vandermeer{at}erasmusmc.nl
Citation
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
Publication history
- Received May 9, 2019
- Revised October 31, 2019
- Accepted November 16, 2019
- First published December 16, 2019.
Online issue publication
August 19, 2020
Article Versions
- Previous version (19 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.